Murata Vios Private Limited - Due diligence report

A 360° intelligence report on Viosmedical: trust score, financial health, credit view, compliance, directors, growth and distress signals - …

2013-09-03 Bangalore, Karnataka Active Unlisted Active Compliant
Share
Connect MCP
MV Murata Vios Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Viosmedical — 360° Intelligence Report

Generated from MCA filings & public records
81/100
Trust Score
Low Risk

Viosmedical is assessed as Low Risk with a Trust Score of 81/100. Viosmedical is an active private limited indian non-government company incorporated in 2013, operating in the Financial Services sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 31 Jul 2026 from the latest processed filings. Murata Vios Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
81/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
MORITARO HAGIWARA 01234567 Director 01/04/2018 6 yrs Approved
SUBRAMANIAM GANESH 01234567 Director 01/04/2018 6 yrs Approved
AMIT RAJENDRA PATEL 01234567 Director 01/04/2018 6 yrs Approved
KOICHI SUGII 01234567 Director 01/04/2018 6 yrs Approved
Fumiyuki Suchi 01234567 Director 01/04/2018 6 yrs Approved
Haruo Mitsuhashi 01234567 Director 01/04/2018 6 yrs Approved
  • 6 directors on the board.
  • KOICHI SUGII has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Murata Vios Inc.
Subsidiaries
-
Group entities
-
Capital events
5 allotment(s) · 2 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Murata Vios Inc. Holding Company 74.00%

Key managerial personnel: KOICHI SUGII (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 12+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence87/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment78/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view73/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
17 Dec 2025
Director appointed
Haruo Mitsuhashi (Additional Director)
18 Nov 2025
Director appointed
Fumiyuki Suchi (Additional Director)
29 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
11 May 2022
Director appointed
KOICHI SUGII (Managing Director)
Director ceased
KOICHI SUGII
30 Sep 2020
Director ceased
KATSUTOSHI NINOMIYA
24 Sep 2018
Director ceased
MORITARO HAGIWARA
Director ceased
HARUO MITSUHASHI
Director ceased
MASANORI MINAMIDE
25 Jul 2018
Director appointed
MORITARO HAGIWARA (Director)
16 Apr 2018
Securities allotted
138251 Equity Shares - 2.56 cr raised
25 May 2015
Securities allotted
301379.00 Equity Shares - 60.28 Lakh raised
31 Mar 2015
Share transfer (FY 2015)
9499.00000000 shares to VIOS MEDICAL INC
Share transfer (FY 2015)
1.00000000 shares to Subramanian Ganesh
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
6 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 5 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Tvlk India Private Limited U73200KA2017FTC106391 Bengaluru, Karnataka, India
Indus Gene Expressions Limited U24231AP2007PLC113311 Chilamathur Mandal, Andhra Pradesh, India
Sci-Tech Centre U01110MH1971GAP015467 Mumbai, Maharashtra, India
Omgene U24230GJ2011PTC064483 Vadodara, Gujarat, India
Lumenis Be (India) Private Limited U51909DL2021PTC383816 Delhi, Delhi, India
Szhaveri U51397MH2005PTC153790 Kalyan, Maharashtra, India
Purita Water Solutions Private Limited U73999MH2005PTC153723 Mumbai, Maharashtra, India
Navin Saxena Research And Technology Private Limited U73100MH1994PTC083220 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Viosmedical before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Viosmedical: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Viosmedical - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 81/100, distress signals and MSME payment-delay disclosures - know whether Viosmedical pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Viosmedical - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Viosmedical an active company?

Viosmedical has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Viosmedical financially healthy?

Viosmedical has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.

Should I do business with Viosmedical?

Its overall Trust Score is 81/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Viosmedical?

The ultimate holding entity is Murata Vios Inc.. 6 active director(s) are on record.

Does Viosmedical have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Viosmedical up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Viosmedical?

Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.